The document discusses the results of a study on the effects of a new drug on memory and cognitive function in older adults. The double-blind study involved giving either a placebo or the experimental drug to 100 volunteers aged 65-80 over 6 months. According to the results, those who received the drug performed significantly better on memory and problem-solving tests compared to the placebo group, suggesting the drug may help slow cognitive decline in older adults.